Lynx Investment Advisory
Position in TMO — Thermo Fisher Scientific Inc.
CIK 2028812
WASHINGTON, DC, DC
Position in TMO
as of Jun 30, 2026
· filed Jul 27, 2026
Position Value
$297,807
+$176,147 QoQ
Shares Held
594
+170.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.28%
of 13F equity value
Holder Rank
#2,054
of 2,606 holders
Holding Since
Jun 2024
2 quarters on record
Voting authority
Sole 99%
Shared 0%
None 1%
Common Shares in TMO Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Lynx Investment Advisory holds $297,807 across 1 Diagnostics & Research name. TMO ranks #1 (100.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
This page
|
594 | $297,807 |
All Filings in TMO
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $297,807 | 594 | Shares | Sole | 2026-07-27 | |
| 2024-06-30 | $121,660 | 220 | Shares | Other | 2024-07-09 | |
| No filing history on record for this holder in this stock. | ||||||